US1477691A - Pharmaceutical product - Google Patents

Pharmaceutical product Download PDF

Info

Publication number
US1477691A
US1477691A US610364A US61036423A US1477691A US 1477691 A US1477691 A US 1477691A US 610364 A US610364 A US 610364A US 61036423 A US61036423 A US 61036423A US 1477691 A US1477691 A US 1477691A
Authority
US
United States
Prior art keywords
pharmaceutical product
sodium
solutions
ketones
valuable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US610364A
Inventor
Callsen Jurgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Farbenfabriken Vorm Friedr Bayer and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farbenfabriken Vorm Friedr Bayer and Co filed Critical Farbenfabriken Vorm Friedr Bayer and Co
Priority to US610364A priority Critical patent/US1477691A/en
Application granted granted Critical
Publication of US1477691A publication Critical patent/US1477691A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Patented Dec. 18, 19.
' runes-n CALLS, or Emmarnm), GERMANY; assreuon, 'ro rmnmran w vonm. ramps. BAYER AND or nnvnaxusma, um cements-owninsums, seamen.
No Drawing.
To all whom it may concern.
Be it known that 1, Jam: CAILSEN, a
citizen of Germany, residing at Elberfeld,
Marienstrasse 106, in the State of Pruxia,
Germany, have invented new and useful Improvements in Pharmaceutical Products, of which the followin is a specification,
It has been found It t saturated or unsaturated hydroaromatic ketones which contain an lsppropy l side chain 'inmeta. position to the keto group (see' Crossley and Pratt, Journal of Chem. Soc, London 107 page 171; Annalen der Chemie 277 ,page 133 and 288, page 328) furnish pharmaceu- 1 tically valuable solutions by treating these products with solutions'of salts of'organic acids- As these ketones show a valuable.
' PEARLIACEUTICAL PRODUCT.
Applicafion M t mm 2, ms. Serial mciosuf tion of sodium selicylate (1 cubic centimeter=0.5 gram sodium 'salicylate). 'A llmpid solution results which can be further diluted'with water without a precipitate beinabtained. J J her of the above mentioned ketones may be used, e. g. 3-methyl 5-isopropylcyclohexanon, 1-isopropylcyclohexan-3 on (J ourn.
of Chem. Soc. London 107, pa e 171), etc. Instead of sodium salieylate 0t er salts of organic acids'may'be-used e. g.. sodium ben-, zoate, the sodium salt 0% meta-oxybenzoic acid, the potassium salt of isovaleric acid etc.
I claim v 1.- The hereinbefore described new solutions ofhydr'oaromatic ketones containing an isopropyl side chain in meta-position to the ket0 group in solutions of salts of ,orgame aci 3, being valuable pharmaceutical products as analeptics, substantially as described.
2. The herein described new solution of I 3-methy l 5-isopropyl-A-2-cyclohexenon in an aqueous solution of sodium, salicylate, being a valuable pharmaceutical product as ananaleptic; substantially as described.
In testimony whereof I have hereunto set my hand.
- JURGEN CALLSEN.
US610364A 1923-01-02 1923-01-02 Pharmaceutical product Expired - Lifetime US1477691A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US610364A US1477691A (en) 1923-01-02 1923-01-02 Pharmaceutical product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US610364A US1477691A (en) 1923-01-02 1923-01-02 Pharmaceutical product

Publications (1)

Publication Number Publication Date
US1477691A true US1477691A (en) 1923-12-18

Family

ID=24444717

Family Applications (1)

Application Number Title Priority Date Filing Date
US610364A Expired - Lifetime US1477691A (en) 1923-01-02 1923-01-02 Pharmaceutical product

Country Status (1)

Country Link
US (1) US1477691A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2581850A (en) * 1948-08-10 1952-01-08 Internat Hormones Inc Adrenochrome compositions
US2789079A (en) * 1953-03-16 1957-04-16 Crookes Lab Inc Orally administrable dry therapeutic composition
US4136119A (en) * 1977-12-30 1979-01-23 The Coca-Cola Company M-menthenone and process for its production

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2581850A (en) * 1948-08-10 1952-01-08 Internat Hormones Inc Adrenochrome compositions
US2789079A (en) * 1953-03-16 1957-04-16 Crookes Lab Inc Orally administrable dry therapeutic composition
US4136119A (en) * 1977-12-30 1979-01-23 The Coca-Cola Company M-menthenone and process for its production

Similar Documents

Publication Publication Date Title
US1477691A (en) Pharmaceutical product
ES294436A1 (en) Preparation of sodium or potassium salts of polymyxin b and e or colistin formaldehyde-bisulfite reaction products
GB1306331A (en)
Searle Experiments on the carcinogenicity and reactivity of β-propiolactone
GB658467A (en) Improvements relating to the production of preparations of penicillin salts
Calandra et al. The preparation of amine derivatives of 2-chloro-1, 4-naphthoquinone
ES197716A1 (en) A PROCEDURE FOR PREPARING A STABLE AQUEOUS SOLUTION OF DIHOROSTERPTOMYCIN
SU1268170A1 (en) Antirheumatoid agent "pyrimidant"
US2261188A (en) Stabilized form of vitamin b6 and process of preparing the same
SU42671A1 (en) The method of preparation of cosmetics
US1589390A (en) Sulphonated thianthrenes useful as pharmaceutical compounds
US2104738A (en) Bismuth allantoinate and process of making it
ES196573A1 (en) PROCEDURE FOR OBTAINING ASYMMETRIC ARSENOBENZOLIC COMBINATIONS
GB1310788A (en) Process for the production of dopa
GB1490247A (en) Process for preparing mono-and di-esters of 2,5-dihydroxybenzene sulphonic acid
GB689877A (en) The thiosemicarbazone of nicotinic aldehyde and process for its preparation
GB546301A (en) Improvements in the manufacture of aromatic compounds containing sulphur
GB300401A (en) Improvements in the manufacture of heavy metal azides
GB692449A (en) Improvements in caustic alkali composition of matter and its use as a poly-valent metal precipitation inhibitor
Suter et al. A STUDY OF SOME PARA-ALKYLPHENOLSULFONIC ACIDS
GB439935A (en) Process for the manufacture of stable solutions of dihydroxy-diamino-arsenobenzene and its derivatives
GB302171A (en)
GB112841A (en) A New or Improved Curative Preparation for Diseases of the Skin.
GB288370A (en) The manufacture of new complex antimony compounds
GB265777A (en) Improved process for the manufacture of organic auro-mercapto acids and salts thereof